JP2016528176A5 - - Google Patents

Download PDF

Info

Publication number
JP2016528176A5
JP2016528176A5 JP2016517683A JP2016517683A JP2016528176A5 JP 2016528176 A5 JP2016528176 A5 JP 2016528176A5 JP 2016517683 A JP2016517683 A JP 2016517683A JP 2016517683 A JP2016517683 A JP 2016517683A JP 2016528176 A5 JP2016528176 A5 JP 2016528176A5
Authority
JP
Japan
Prior art keywords
protein
nucleic acid
acid molecule
hbcag
copies
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2016517683A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016528176A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/GB2014/051739 external-priority patent/WO2014195713A1/en
Publication of JP2016528176A publication Critical patent/JP2016528176A/ja
Publication of JP2016528176A5 publication Critical patent/JP2016528176A5/ja
Pending legal-status Critical Current

Links

JP2016517683A 2013-06-06 2014-06-05 シングルドメイン抗体ディスプレイ Pending JP2016528176A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361831707P 2013-06-06 2013-06-06
US61/831,707 2013-06-06
PCT/GB2014/051739 WO2014195713A1 (en) 2013-06-06 2014-06-05 Single domain antibody display

Publications (2)

Publication Number Publication Date
JP2016528176A JP2016528176A (ja) 2016-09-15
JP2016528176A5 true JP2016528176A5 (https=) 2017-07-13

Family

ID=51022893

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016517683A Pending JP2016528176A (ja) 2013-06-06 2014-06-05 シングルドメイン抗体ディスプレイ

Country Status (6)

Country Link
US (1) US20160122420A1 (https=)
EP (1) EP3004173B1 (https=)
JP (1) JP2016528176A (https=)
CN (1) CN105431457A (https=)
CA (1) CA2914555A1 (https=)
WO (1) WO2014195713A1 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201402890D0 (en) 2014-02-18 2014-04-02 Iqur Ltd Vaccines based on hepatitis B Core antigens
GB201421692D0 (en) * 2014-12-05 2015-01-21 Iquar Ltd Vaccines based on hepatitis B core antigens
US10544210B2 (en) * 2015-02-03 2020-01-28 Inserm (Institut National De La Sante Et De La Recherche Medicale) Anti-Rho GTPase conformational single domain antibodies and uses thereof
US11078240B2 (en) 2016-11-11 2021-08-03 Fraunhofer Usa Inc. Covalently fused viral coat proteins for the display of target molecules
CN113138276B (zh) * 2020-01-19 2022-09-16 厦门万泰凯瑞生物技术有限公司 用于检测HBcAg的方法及抗体
WO2021168575A1 (en) * 2020-02-27 2021-09-02 Quadrumix Biotechnology Inc. Polypeptides directed against viral infection and uses thereof

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2489769A1 (en) 1989-03-21 1990-10-04 Philip L. Felgner Expression of exogenous polynucleotide sequences in a vertebrate
US5279833A (en) 1990-04-04 1994-01-18 Yale University Liposomal transfection of nucleic acids into animal cells
US5283185A (en) 1991-08-28 1994-02-01 University Of Tennessee Research Corporation Method for delivering nucleic acids into cells
CA2131620A1 (en) 1992-03-20 1993-09-30 Louis C. Smith A dna transporter system and method of use
WO1993019768A1 (en) 1992-04-03 1993-10-14 The Regents Of The University Of California Self-assembling polynucleotide delivery system
US5651981A (en) 1994-03-29 1997-07-29 Northwestern University Cationic phospholipids for transfection
US5527928A (en) 1994-09-30 1996-06-18 Nantz; Michael H. Cationic transport reagents
DE60122300T2 (de) * 2000-04-07 2007-08-30 The University Of Leeds Hepatitis b kernprotein fusionsproteine
JP4791730B2 (ja) 2002-09-27 2011-10-12 パウダージェクト リサーチ リミテッド 核酸コーティング粒子
US20120015899A1 (en) * 2008-10-25 2012-01-19 Plant Bioscience, Limited Modified plant virus particles and uses therefor
GB0918679D0 (en) * 2009-10-23 2009-12-09 Iqur Ltd Influenza vaccine
US20130017210A1 (en) * 2010-03-17 2013-01-17 Stc.Unm Display of antibody fragments on virus-like particles of rna bacteriophages

Similar Documents

Publication Publication Date Title
Sun et al. Interferon-armed RBD dimer enhances the immunogenicity of RBD for sterilizing immunity against SARS-CoV-2
Saif Vaccines for COVID-19: perspectives, prospects, and challenges based on candidate SARS, MERS, and animal coronavirus vaccines
JP2016528176A5 (https=)
Christensen et al. Profound protection against respiratory challenge with a lethal H7N7 influenza A virus by increasing the magnitude of CD8+ T-cell memory
Ibañez et al. M2e-displaying virus-like particles with associated RNA promote T helper 1 type adaptive immunity against influenza A
JP2011521662A5 (https=)
JP2016505635A5 (https=)
WO2014018858A3 (en) Multimeric fusion protein vaccine and immunotherapeutic
JP2012525128A5 (https=)
JP2017507117A5 (https=)
Fang et al. Novel strategies for the development of hand, foot, and mouth disease vaccines and antiviral therapies
JP2011519869A5 (https=)
JP2017515508A5 (https=)
JP2017526689A5 (https=)
JP7382634B2 (ja) 交差免疫抗原ワクチン及びその調製方法
JP2018500878A5 (https=)
JP2017511140A5 (https=)
JP2015529677A5 (https=)
JP2018517419A5 (https=)
RU2018101722A (ru) Днк-вакцина, нацеленная на vegfr-2, для комбинированной терапии
Zhang et al. DNA-based influenza vaccines as immunoprophylactic agents toward universality
Leclerc et al. A novel M2e based flu vaccine formulation for dogs
JP2014502143A5 (https=)
Rico et al. Venezuelan and western equine encephalitis virus E1 liposome antigen nucleic acid complexes protect mice from lethal challenge with multiple alphaviruses
JP2013518563A5 (https=)